Intensive lipid‐lowering therapy in the 12 months after an acute coronary syndrome in Australia: an observational analysis
Author:
Affiliation:
1. Concord Repatriation General Hospital Sydney NSW
2. University of Sydney School of Public Health Sydney NSW
3. Clinical Research CentreSydney Local Health District Sydney NSW
4. ANZAC Research Institute Sydney NSW
5. St George Hospital Sydney NSW
Funder
Sanofi Australia
Publisher
AMPCo
Subject
General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.5694/mja2.12035
Reference21 articles.
1. Deloitte Access Economics.ACS in perspective: the importance of secondary prevention. Nov 2011.https://www2.deloitte.com/content/dam/Deloitte/au/Documents/Economics/deloitte-au-economics-acs-perspective-importance-secondary-prevention-011111.pdf(viewed Sept 2018).
2. Utilization of and Adherence to Guideline-Recommended Lipid-Lowering Therapy After Acute Coronary Syndrome
3. Effects of Atorvastatin on Early Recurrent Ischemic Events in Acute Coronary SyndromesThe MIRACL Study: A Randomized Controlled Trial
4. 2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Heart Foundation launches new MyHeart MyLife patient support program;Heart, Lung and Circulation;2024-09
2. Patterns of 12-Month Post-Myocardial Infarction Medication Use According to Revascularisation Strategy: Analysis of 15,339 Admissions in Victoria, Australia;Heart, Lung and Circulation;2024-07
3. Use of secondary prevention medications in metropolitan and non-metropolitan areas: an analysis of 41 925 myocardial infarctions in Australia;European Journal of Preventive Cardiology;2023-11-21
4. Optimising adherence to secondary prevention medications following acute coronary syndrome utilising telehealth cardiology pharmacist clinics: a matched cohort study;International Journal of Clinical Pharmacy;2023-03-20
5. A Systematic Review of Lipid Management in Secondary Prevention and Comparison of International Lipid Management Pathways;Cureus;2023-02-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3